Get access

Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings

Authors

  • Lisa J. Herrinton PhD,

    Corresponding author
    1. Division of Research, Kaiser Permanente Northern California, Oakland, CA; HMO Research Network CERT
    • Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612
    Search for more papers by this author
  • Liyan Liu MD,

    1. Division of Research, Kaiser Permanente Northern California, Oakland, CA; HMO Research Network CERT
    Search for more papers by this author
  • Jennifer Elston Lafata PhD,

    1. Center for Health Services Research, Henry Ford Health System, Detroit, MI; HMO Research Network CERT
    Search for more papers by this author
  • James E. Allison MD,

    1. Division of Gastroenterology, Department of Internal Medicine, University of California, San Francisco, CA
    Search for more papers by this author
  • Susan E. Andrade ScD,

    1. Meyers Primary Care Institute (University of Massachusetts Medical School and Fallon Foundation); HMO Research Network CERT
    Search for more papers by this author
  • Eli J. Korner PharmD,

    1. Clinical Research Unit, Kaiser Permanente Colorado, Aurora, CO; School of Pharmacy, University of Colorado Health Sciences Center, Denver, CO; HMO Research Network CERT
    Search for more papers by this author
  • K. Arnold Chan ScD, MD,

    1. Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School; Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School; HMO Research Network CERT
    Search for more papers by this author
  • Richard Platt MD,

    1. Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School; Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School; HMO Research Network CERT
    Search for more papers by this author
  • Deborah Hiatt RN, MPH,

    1. Centers for Disease Control and Prevention, National Center for Infectious Diseases, Atlanta, GA
    Search for more papers by this author
  • Siobhán O'Connor MD, MPH

    1. Centers for Disease Control and Prevention, National Center for Infectious Diseases, Atlanta, GA
    Search for more papers by this author

Abstract

Background: There are few contemporary estimates of prevalence rates for inflammatory bowel disease (IBD) in diverse North American communities.

Methods: We estimated the period prevalence of IBD for January 1, 1999, through June 30, 2001, among 1.8 million randomly sampled members of nine integrated healthcare organizations in the US using computerized diagnoses and outpatient pharmaceutical dispensing. We also assessed the positive predictive value (PPV) and sensitivities of 1) the case-finding algorithm, and 2) the 30-month sampling period using medical chart review and linkage to a 78-month dataset, respectively.

Results: The PPV of the case-finding algorithm was 81% (95% confidence interval [CI], 78–87) and 84% (95% CI, 79–89) in two different organizations. In both, the sensitivity of the optimal algorithm, compared with the most inclusive, exceeded 90%. The sensitivity of the 30-month sampling period compared with 78 months was 61% (95% CI, 57–64) in one organization. Applying a slightly more sensitive case-finding algorithm, the average period prevalence of IBD across the nine organizations, standardized to the age- and gender-distribution of the US population, 2000 census, was 388 cases (95% CI, 378–397) per 100,000 persons (range 209–784 per 100,000; average follow-up 26 months). The prevalence of Crohn's disease, ulcerative colitis, and unspecified IBD was 129, 191, and 69 per 100,000, respectively.

Conclusions: The observed average prevalence was similar to prevalence proportions reported for other North American populations (369–408 per 100,000). Additional research is needed to understand differences in the occurrence of IBD among diverse populations as well as practice variation in diagnosis and treatment of IBD.

(Inflamm Bowel Dis 2007)

Get access to the full text of this article

Ancillary